Ask a doctor about a prescription for DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS
Package Leaflet: Information for the User
Demilos 600 mg/ 2,000 UI Orodispersible Tablets
Calcium / Colecalciferol
This medicine is used to treat calcium and vitamin D deficiency in adults.
This medicine contains calcium and vitamin D3, both important components in bone formation. Vitamin D3 regulates calcium absorption and metabolism, as well as calcium incorporation into bones.
Ask your doctor or pharmacist if you have any questions and always follow their instructions.
You should consult a doctor if it gets worse or does not improve within a few days.
Consult your doctor or pharmacist before starting to take Demilos 600 mg/ 2,000 UI.
Children and Adolescents
Demilos 600 mg/ 2,000 UI is not recommended for use in children or adolescents.
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
The effect of treatment may be affected if this medicine is taken at the same time as other medicines used for:
Please make sure your doctor knows if you are taking any of the medicines listed above. Your dose may need to be adjusted.
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
If you are taking medicines for:
Calcium absorption may be inhibited by foods containing oxalic acid (found in spinach and rhubarb) or phytic acid (found in most cereals). It is recommended not to take this medicine during the 2 hours following the intake of foods with high oxalic or phytic acid content.
This medicine is not recommended during pregnancy.
Demilos 600 mg/ 2,000 UI can be taken during breast-feeding. Calcium and vitamin D3 pass into breast milk. This should be taken into account when administering additional vitamin D to the baby. Supplementation with Demilos 600 mg/ 2,000 UI does not replace the administration of vitamin D in newborns.
If you are pregnant or breast-feeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Driving and Using Machines:
No effects on the ability to drive and use machines have been observed. |
Demilos 600 mg/ 2,000 UI contains aspartame, lactose, sucrose, and partially hydrogenated soybean oil
This medicine contains 8.67 mg of aspartame in each tablet.
Aspartame is a source of phenylalanine, which may be harmful in case of phenylketonuria (PKU), a rare genetic disorder in which phenylalanine accumulates due to the body's inability to eliminate it properly.
This medicine contains lactose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine. It may cause tooth decay.
This medicine contains soybean oil. It should not be used in case of peanut or soy allergy.
Follow the instructions for administration of this medicine exactly as prescribed by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist again.
The recommended dose is established by your doctor for you individually.
The usual dose is: 1 tablet per day.
The tablets should be dissolved in the mouth. They should not be swallowed whole.
The tablets should be taken preferably after meals.
The amount of calcium in Demilos 600 mg/ 2,000 UI is less than the daily recommended intake. Therefore, this medicine is recommended for patients who need an additional intake of vitamin D but have a daily calcium intake of 500-1,000 mg per day. Your doctor should estimate your daily calcium intake through your diet.
Use in Children and Adolescents
Demilos 600 mg/ 2,000 UI is not indicated for use in children and adolescents.
Call your doctor or pharmacist immediately if you take more of this medicine than prescribed by your doctor. You can also contact the Toxicology Information Service, phone 91 562 04 20, indicating the medicine and the amount taken.
The symptoms of a possible overdose of Demilos 600 mg/ 2,000 UI may include loss of appetite, thirst, excessive urination, nausea, vomiting, and constipation.
Do not take a double dose to make up for forgotten doses.
Take it as soon as you remember. Then take the next dose as usual. However, if it is already time for your next dose, skip the missed dose and take only one dose as usual.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should stop taking this medicine and inform your doctor immediately if you experience symptoms of serious allergic reactions such as:
Uncommon side effects (may affect up to 1 in 100 people):hypercalcemia (elevated blood calcium levels) and/or hypercalciuria (elevated urine calcium levels).
Rare side effects (may affect less than 1 in 1,000 people):constipation, flatulence, nausea, abdominal distension (pain), diarrhea, pruritus (itching), rash, and urticaria.
Unknown frequency side effects (cannot be estimated from the available data):serious allergic reactions.
Other special populations
Patients with renal insufficiency may have a potential risk of hyperphosphatemia, nephrolithiasis, and nephrocalcinosis.
Reporting of Side Effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Medicines should not be disposed of via wastewater or household waste. Return any unused medicine to your pharmacist. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The active substances are calcium carbonate 1,500 mg, corresponding to 600 mg of calcium, and colecalciferol 2,000 UI (vitamin D3) corresponding to 0.050 mg.
The other ingredients are: maltodextrin, anhydrous citric acid (E330), low-substituted hydroxypropylcellulose (E463), lactose monohydrate, stearic acid, aspartame (E951), sucrose, gelatin, orange flavor (natural flavorings, maltodextrin, dextrin), corn starch, partially hydrogenated soybean oil, all-rac-α-tocopherol (E307), silicon dioxide.
Orodispersible tablets are white or almost white, circular, and beveled.
Bottle of 30 tablets.
Multi-pack of 60 (2 packs of 30) orodispersible tablets.
Not all pack sizes may be marketed.
Marketing Authorization Holder: ITALFARMACO, S.A.
San Rafael, 3 – 28108 Alcobendas (Madrid), SPAIN
Tel.: 916572323
Manufacturer: ITALFARMACO, S.p.A.
Viale Fulvio Testi 330
Milan (ITALY)
Tel.: 39 02 6443.1
This medicine is authorized in the Member States of the European Economic Area under the following names:
| |
|
Date of Last Revision of this Leaflet: June 2020
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es/
The average price of DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS in October, 2025 is around 18.01 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for DEMILOS 600 MG/2000 IU ORALLY DISINTEGRATING TABLETS – subject to medical assessment and local rules.